Navigation Links
Align Technology Announces Second Quarter Fiscal 2009 Results
Date:7/23/2009

SANTA CLARA, Calif., July 23 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the second quarter, ended June 30, 2009.

Total net revenues for the second quarter of fiscal 2009 (Q2 09) were $76.3 million compared to $70.1 million reported in the first quarter of 2009 (Q1 09) and compared to $79.9 million reported in the second quarter of 2008 (Q2 08). Invisalign case shipments for Q2 09 were 53.0 thousand, compared to 50.1 thousand in Q1 09 and compared to 54.9 thousand in Q2 08.

Net profit for Q2 09 was $4.5 million, or $0.07 per diluted share. This is compared to net profit of $2.6 million, or $0.04 per diluted share in Q1 09 and net profit of $4.0 million, or $0.06 per diluted share in Q2 08. Stock-based compensation expense included in Q2 09 net profit was $4.3 million compared to $3.7 million in Q1 09 and $4.8 million in Q2 08.

"Overall, we had a good quarter with better than expected results across the board, including record gross margins and continued profitability," said Thomas M. Prescott, president and CEO of Align Technology. "Second quarter revenues increased 9% sequentially to $76.3 million on case shipments of 53.0 thousand, driven by strong international growth and continued uptake of Invisalign Teen."

To supplement our consolidated financial statements, we use the following non-GAAP financial measures: non-GAAP operating expense, non-GAAP operating margin, non-GAAP net profit and non-GAAP earnings per share. For Q2 09, the non-GAAP financial measures excluded the impact of the Company's restructuring plan announced previously. A detailed reconciliation between GAAP and non-GAAP information is contained in the tables following the financial tables of this release.

Non-GAAP net profit for Q2 09 was $4.8 million, or $0.07 per diluted share. This is compared to non-GAAP net profit of $3.2 million, or $0.05 per diluted share in Q1 09. In Q2 08, there was no difference between GAAP and non-GAAP net profit.

Q2 09 Operating Results

    Key GAAP Operating Results              Q2 09       Q1 09       Q2 08
                                            -----       -----       -----
    Gross Margin                            76.0%       75.2%       74.7%
    Operating Expense                      $51.7M      $47.4M      $55.8M
    Operating Margin                         8.2%        7.5%        4.8%
    Net Profit                              $4.5M       $2.6M       $4.0M
    Earnings Per Diluted Share (EPS)       $0.07       $0.04       $0.06

    Key Non-GAAP Operating Results          Q2 09       Q1 09       Q2 08
                                            -----       -----       -----
    Non-GAAP Operating Expense             $51.3M      $46.5M      $55.8M
    Non-GAAP Operating Margin                8.7%        8.8%        4.8%
    Non-GAAP Net Profit                     $4.8M       $3.2M       $4.0M
    Non-GAAP Earnings Per Diluted
     Share (EPS)                           $0.07       $0.05       $0.06

Liquidity and Capital Resources

As of June 30, 2009, Align had $143.1 million in cash, cash equivalents, and short-term marketable securities compared to $110.2 million as of December 31, 2008.

Key Business Metrics

The following table highlights business metrics for Align's second quarter of 2009. Additional historical information is available on the Company's website athttp://investor.aligntech.com.

                                                     % of Total    Q2 09/Q1 09
    Revenue by Channel ($M):              Q2 09        Revenue     % Change
                                          -----      ----------    --------
    North American Orthodontists          $21.6         28.3%          2.3%
    North American GP Dentists            $31.7         41.6%          2.7%
    International                         $18.1         23.6%         26.6%
    Non-case Revenue*                      $4.9          6.5%         27.6%
                                           ----          ---          ----
    Total Revenue                         $76.3          100%          8.8%
                                          =====          ===           ===
    *includes training, ancillary
     products, and retainers

    Cases Shipped by Channel:                        % of Total    Q2 09/Q1 09
                                          Q2 09         Cases      % Change
                                          -----      ----------    --------
    North American Orthodontists         17,470         33.0%          3.4%
    North American GP Dentists           23,525         44.4%          0.8%
    International                        12,010         22.6%         22.1%
                                         ------         ----          ----
    Total Cases Shipped                  53,005          100%          5.9%
                                         ======          ===           ===


    Cases Shipped by Product:                        % of Total    Q2 09/Q1 09
                                          Q2 09         Cases      % Change
                                          -----      ----------    --------
    Invisalign Full                      37,840         71.4%          1.6%
    Invisalign Express                    8,000         15.1%         (0.1%)
    Invisalign Teen                       5,940         11.2%         52.5%
    Invisalign Assist                     1,225          2.3%         34.7%
                                          -----          ---          ----
    Total Cases Shipped                  53,005          100%          5.9%
                                         ======          ===           ===

    Average Selling Price (ASP),          Q2 09
     as billed:                           -----
    Total Worldwide Blended ASP          $1,400
    International ASP                    $1,530

    Number of Doctors Cases were          Q2 09
     Shipped to:                          -----
    North American Orthodontists          3,750
    North American GP Dentists           10,630
    International                         3,385
                                          -----
    Total Doctors Cases were
     Shipped to Worldwide                17,765
                                         ======

    Number of Doctors Trained             Q2 09     Cumulative
     Worldwide:                           -----     ----------
    North American Orthodontists             65        8,805
    North American GP Dentists              900       34,375
    International                           515       15,030
                                            ---       ------
    Total Doctors Trained
     Worldwide                            1,480       58,210
                                          =====       ======


    Doctor Utilization Rates*:            Q2 09         Q1 09         Q2 08
                                          -----         -----         -----
    North American Orthodontists            4.7          4.6           4.9
    North American GP Dentists              2.2          2.2           2.5
    International                           3.6          3.2           3.3
                                            ---          ---           ---
    Total Utilization Rate                  3.0          2.9           3.1
                                            ===          ===           ===

    * Utilization = # of cases shipped/# of doctors to whom cases were shipped

    Total Invisalign Patients
    (cases shipped):                      Q2 09     Cumulative
                                          -----     ----------
    Number of Patients Treated or in
     Treatment (cases)                    53,005     1,047,120
                                          ======     =========

Q3 Fiscal 2009 Business Outlook

For the third quarter of fiscal 2009 (Q3 09), Align Technology expects net revenues to be in a range of $71.0 million to $74.5 million. GAAP earnings per diluted share for Q3 09 is expected to be in a range of $0.03 to $0.05. Stock-based compensation expense for Q3 09 is expected to be approximately $4.6 million.

A more comprehensive business outlook is available following the financial tables of this release.

Align Web Cast and Conference Call

Align Technology will host a conference call today, July 23, 2009 at 4:30 p.m. ET, 1:30 p.m. PT, to review its second quarter fiscal 2009 results, discuss future operating trends and business outlook. The conference call will also be web cast live via the Internet. To access the web cast, go to the "Events & Presentations" section under Company Information on Align Technology's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call. If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 327280 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on August 6, 2009.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit www.invisalign.com or call 1-800-INVISIBLE.

About non-GAAP Financial Measures

To supplement our consolidated financial statements and our business outlook, we use the following non-GAAP financial measures: non-GAAP operating expenses, non-GAAP profit from operations, non-GAAP net profit, and non-GAAP earnings per share, which exclude the effect of charges associated with the restructuring, and the related tax effect. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. For more information on these non-GAAP financial measures, please see the tables captioned "Business Outlook Summary" included at the end of this release.

We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our "core operating performance". Management believes that "core operating performance" represents Align's performance in the ordinary, ongoing and customary course of its operations. Accordingly, management excludes from "core operating performance" certain expenditures and other items that may not be indicative of our operating performance including discrete cash charges that are infrequent or one-time in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are provided to and used by our institutional investors and the analyst community to facilitate comparisons with prior and subsequent reporting periods.

Forward-Looking Statement

This news release, including the tables below, contains forward-looking statements, including statements regarding, certain business metrics for the third quarter of 2009, including anticipated revenue, gross margin, operating expense, operating income, earnings per share, case shipments and cash. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, difficulties predicting customer and consumer purchasing behavior as well as the willingness and ability of our customers to adopt the expected baseline requirements set forth in our recently announced proficiency program and the willingness and ability of our customers to maintain and/or increase utilization to meet the new proficiency standards in sufficient numbers, potential losses or damages arising from any legal settlements or judgments related to the Ormco litigation, including the issuance of a permanent injunction, or other equitable relief, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, continued customer demand for Invisalign and new products, changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence, the timing of case submissions from our doctors within a quarter, acceptance of Invisalign by consumers and dental professionals, Align's third party manufacturing processes and personnel, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, competition from manufacturers of traditional braces and new competitors, Align's ability to develop and successfully introduce new products and product enhancements, and the loss of key personnel. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2008, which was filed with the Securities and Exchange Commission on February 27, 2009. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

    Investor Relations Contact                    Press Contact
    Shirley Stacy                                 Shannon Mangum Henderson
    Align Technology, Inc.                        Ethos Communication, Inc.
    (408) 470-1150                                (678) 261-7803
    sstacy@aligntech.com                          align@ethoscommunication.com

    ALIGN TECHNOLOGY, INC.
    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    (in thousands, except per share data)


                                 Three Months Ended     Six Months Ended
                                 ------------------     ----------------
                                 June 30,   June 30,   June 30,   June 30,
                                   2009       2008       2009       2008
                                ---------  ---------  ---------  ---------

    Net revenues                  $76,316    $79,902   $146,448   $154,678

    Cost of revenues               18,338     20,243     35,763     39,851
                                   ------     ------     ------     ------

    Gross profit                   57,978     59,659    110,685    114,827
                                   ------     ------    -------    -------

    Operating expenses:
      Sales and marketing          29,108     32,464     56,962     60,523
      General and
       administrative              16,539     16,322     30,007     31,510
      Research and development      5,669      7,001     10,860     14,296
      Restructuring                   409          -      1,319          -
                                      ---        ---      -----        ---
    Total operating expenses       51,725     55,787     99,148    106,329
                                   ------     ------     ------    -------

    Profit from operations          6,253      3,872     11,537      8,498

    Interest and other income, net    557        443        705      1,409
                                      ---        ---        ---      -----

    Profit before income taxes      6,810      4,315     12,242      9,907

    Provision for income taxes     (2,265)      (285)    (5,061)      (573)
                                   ------       ----     ------       ----

    Net profit                     $4,545     $4,030     $7,181     $9,334
                                   ======     ======     ======     ======

    Net profit per share
         - basic                    $0.07      $0.06      $0.11      $0.14
                                    =====      =====      =====      =====
         - diluted                  $0.07      $0.06      $0.11      $0.13
                                    =====      =====      =====      =====

    Shares used in computing net
     profit per share
         - basic                   66,285     68,581     66,135     68,817
                                   ======     ======     ======     ======
         - diluted                 67,373     69,916     66,941     70,478
                                   ======     ======     ======     ======



    ALIGN TECHNOLOGY, INC.
    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
    (in thousands)

                                                       June 30,   December 31,
                                                         2009         2008

                          ASSETS

    Current assets:
      Cash and cash equivalents                        $122,182       $87,100
      Marketable securities, short-term                  20,895        23,066
      Accounts receivable, net                           53,236        52,362
      Inventories, net                                    2,111         1,965
      Other current assets                               15,324        13,414
                                                         ------        ------
           Total current assets                         213,748       177,907

    Property and equipment, net                          24,518        26,979
    Goodwill and intangible assets, net                   6,866         8,266
    Deferred tax asset                                   61,133        61,696
    Other long-term assets                                1,529         4,493
                                                          -----         -----

             Total assets                              $307,794      $279,341
                                                       ========      ========


           LIABILITIES AND STOCKHOLDERS' EQUITY

    Current liabilities:
      Accounts payable                                   $6,473        $5,580
      Accrued liabilities                                40,200        38,282
      Deferred revenue                                   23,138        16,710
                                                         ------        ------
           Total current liabilities                     69,811        60,572

    Other long term liabilities                             205           229
                                                            ---           ---

            Total liabilities                            70,016        60,801

    Total stockholders' equity                          237,778       218,540
                                                        -------       -------

          Total liabilities and stockholders'
           equity                                      $307,794      $279,341
                                                       ========      ========

    ALIGN TECHNOLOGY, INC.
    RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS



    Reconciliation of GAAP to
     Non-GAAP Operating Expenses
    (in thousands)
                                                 Three Months Ended
                                                --------------------
                                         June 30,    March 31,  June 30,
                                           2009        2009       2008
                                        ---------     ------   ---------

    GAAP Operating expenses               $51,725     $47,423    $55,787
      Restructuring                          (409)       (910)         -
                                             ----        ----        ---
    Non-GAAP Operating expenses           $51,316     $46,513    $55,787
                                          =======     =======    =======


    Reconciliation of GAAP to
    Non-GAAP Profit from Operations
    (in thousands)
                                                 Three Months Ended
                                                --------------------
                                         June 30,    March 31,  June 30,
                                           2009        2009       2008
                                        ---------    --------  ---------

    GAAP Profit from Operations            $6,253      $5,284     $3,872
      Restructuring                           409         910          -
                                              ---         ---        ---
    Non-GAAP Profit from Operations        $6,662      $6,194     $3,872
                                           ======      ======     ======


    Reconciliation of GAAP to
     Non-GAAP Net Profit
    (in thousands, except per share
     amounts)
                                                 Three Months Ended
                                                --------------------
                                         June 30,    March 31, June 30,
                                           2009        2009      2008
                                        ---------    --------  ---------

    GAAP Net profit                        $4,545     $2,636     $4,030
      Restructuring                           409        910          -
      Tax effect on non-GAAP
       adjustments                           (127)      (355)         -
                                             ----       ----        ---
    Non-GAAP Net profit                    $4,827     $3,191     $4,030
                                           ======     ======     ======

    Diluted Net profit per share:
        GAAP                                $0.07      $0.04      $0.06
                                            =====      =====      =====
        Non-GAAP                            $0.07      $0.05      $0.06
                                            =====      =====      =====

    Shares used in computing diluted
     net profit per share                  67,373     66,447     69,916
                                           ======     ======     ======


    ALIGN TECHNOLOGY, INC.
    BUSINESS OUTLOOK SUMMARY
    (unaudited)

    The outlook figures provided below and elsewhere in this press release
    are approximate in nature since Align's business outlook is difficult to
    predict.  Align's future performance involves numerous risks and
    uncertainties and the company's results could differ materially from the
    outlook provided.  Some of the factors that could affect Align's future
    financial performance and business outlook are set forth under "Forward
    Looking Information" above in this press release.

    GAAP Financials
    (in millions, except per share amounts and percentages)

                                                  Q3 2009
                                                  -------
    Net Revenue                                $71.0 - $74.5

    Gross Margin                               75.0% - 75.5%

    Operating Expenses                         $49.0 - $50.5

    Operating Margin                              6% - 8%

    Net Income per Diluted Share               $0.03 - $0.05

    Stock Based Compensation Expense:
    Cost of Revenues                               $0.4
    Operating Expenses                             $4.2
                                                   ----
    Total Stock Based Compensation Expense         $4.6

    Business Metrics:
                                                  Q3 2009
                                                  -------
    Case Shipments                             51.0K - 53.0K
    Cash                                       $150M - $155M
    DSO                                           mid 60's
    Capex                                      $2.0M - $4.0M
    Depreciation & Amortization                $2.0M - $3.0M
    Diluted Shares Outstanding                      68M

    Full Year 2009:                               FY 2009

    Stock Based compensation                      $16.8M
    Diluted Shares Outstanding                      68M



'/>"/>
SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Align Technology Provides Update on Patent Litigation with Ormco Corporation
2. Orthocare Innovations Receives Prestigious R&D 100 Award for Computerized Prosthesis Alignment System
3. David Nagel Joins Align Technology Board of Directors
4. Health Information Technology and Health Care Reform Must Be Well-Aligned to Improve Health and Lower Costs
5. Align Technology to Announce Second Quarter Fiscal 2009 Results on July 23, 2009
6. Jury Renders Verdict for Ormco - Aligns Invisalign(R) Product Infringes Ormco Patent
7. Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation
8. Cell Protein Could Help Spur Malignancy
9. GS1 Canada and GHX Align to Make Canadas Healthcare Supply Chain More Efficient and Effective
10. Align Technology Executive to Present at Upcoming Financial Conference
11. Many Childhood Cancer Survivors Not Checking for Second Malignancies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... clinical outcomes, hosted members and suppliers for its inaugural Member Conference at the ... their mission of elevating the operational health of America’s healthcare providers. , The ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through ... a partner for the Tamika Catchings Legacy Tour that will commemorate the ... in hardwood basketball surfaces in all forms and levels of the game, Connor Sports ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
(Date:5/26/2016)... ... ... There are nearly 14.5 million people living with and beyond cancer in the ... 2016, communities around the world will gather to recognize these cancer survivors as part ... is an annual worldwide Celebration of Life that is held on the first Sunday ...
(Date:5/26/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... global clinical supply services, today announced two key appointments and the opening of ... strategic growth plans in the Asia Pacific region. , Howard Kim has joined ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama Information, ... billion in 2015.  Though these are challenging times ... opportunity for success for companies that remain optimistic ... of new growth prospects medical device companies spend ... and development (R&D) than do companies in other ...
(Date:5/25/2016)... PARIS , May 25, 2016 ... system disorders, announces that an oral presentation entitled "High doses ... the MS-SPI trial" will be given by Professor Ayman ... the 2nd Congress of the European Academy of Neurology (EAN) ... "MS and related disorders 3" will take place on Sunday, ...
Breaking Medicine Technology: